Douglas MacKay, ND: Defining the Regulatory Landscape for Hemp-based Supplements.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): Benson, Dick
  • Source:
    Alternative Therapies in Health & Medicine. 2019 Supplement 2, Vol. 25, p16-20. 5p.
  • Additional Information
    • Subject Terms:
      DRUG approval; OMEGA-3 fatty acids
    • Abstract:
      An interview with Douglas MacKay, a senior vice president, scientific and regulatory affairs for CV Sciences is presented. Topics discussed include talking about isolated Cannabidiol (CBD) that is already an approved prescription drug for two serious forms of epilepsy; and mentions that food and supplements should be derived from hemp extracts, as opposed to low-Tetrahydrocannabinol (THC), drug-type, cannabis cultivars.